Page 25 - Sohini Das

CDSCO cracks whip on drug manufacturing units over quality lapses

Shuts down 36% of facilities for failing to meet quality standards

40% investment by TaMo CV arm in FY25 to be in advanced tech: Girish Wagh

"We will continue to invest in software," Wagh said, adding capex in the CV business would be around 2-4 per cent of revenues

CAFE III emission targets to disrupt PV market trends 2027 onwards: Chandra

Shailesh Chandra, managing director, Tata Motors Passenger Vehicles and Tata Passenger Electric Mobility, said that CAFE III standards, which will hit the industry around 2027

Demerger will help secure synergies in EVs, autonomous vehicles: TaMo chief

PV business will invest in vehicle platforms, products; CV business will focus on spares, smart mobility solutions to reduce the volatility of vehicle sales

Sun Pharma completes Taro merger, acquires all outstanding shares

New York headquartered Taro has operations in the US, Canada, Israel, and Japan with manufacturing facilities in Canada (Brampton) and Israel (Haifa)

Bharat Bio moves to include ICMR as co-owner in patent filings for Covaxin

As firm corrects 'inadvertent' mistake, experts feel it's not uncommon to add new parties to patent filings

Imports of bulk drugs grew by 13.06% in April-May as prices cooled

Industry insiders say pharma players are taking advantage and stocking up on APIs

Meril launches indigenously developed knee-replacement robotic system

The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market

Emcure Pharmaceuticals gets market regulator Sebi's approval for IPO

IPO comprises fresh issue of equity shares worth Rs 800 crore and OFS of 13.6 million equity shares by promoters

Tata Motors-owned JLR drives up plan to invest Rs 1.9 trn till FY28

20% increase till FY28; firm eyes double-digit Ebit of 10% by FY26

Dr Reddy's Laboratories, Warburg Pincus, EQT frontrunners to buy BSV

Advent looking to exit 4 years after it picked up majority stake in biopharma firm

How Alkem's 83-year-old founder is remaking India's 4th-largest pharma firm

Hailing from Okari, a remote village in Jehanabad district of Bihar, Singh and his brother, Samprada, moved to Mumbai in 1973 to start Alkem Laboratories with a seed capital of Rs 5 lakh

Approval timelines for clinical trial applications back to pre-Covid days

During pandemic, process was faster and nods for Covid-19 trials came in 30 days

Daughters Inc: The unfolding of succession at Indian family businesses

Of the 2,348 companies listed on the National Stock Exchange, 510 have women executive directors

Eye on the green future, auto companies line up over Rs 2 trillion

Last week Tata Motors, the country's market leader in electric vehicles (EVs), said it was planning to spend Rs 16,000-18,000 crore as capital expenditure on its EV arm till FY30

The green journey: Cleaner fuels driving one-fifth of PVs sold in India

Auto original equipment manufacturers (OEMs) have focused on launching CNG variants of their popular models to meet consumer demand for vehicles with lower running costs

Tractor sales harvest early monsoon benefits in FY25, shows revival signs

Companies report a buoyant sentiment among farmers with the onset of the monsoon

Utility vehicles log 50% higher exports in May over low base: Siam

The export growth has been led by companies like Hyundai Motor India Ltd (HMIL), Honda Cars India, and Volkswagen India, the data showed.

Meet JP Nadda, man behind Indradhanush back to steer health agenda

Nadda is considered a key decision-maker in the BJP and a close aide of PM Narendra Modi. He has been the national president of the BJP since 2020 and a member of the Rajya Sabha from Gujarat

Dr Reddy's Laboratories eyes acquisitions to drive growth in India

The share of chronic has been steadily rising in the Rs 2 lakh crore domestic pharma market- from 36.4 percent in January 2022 to 38.1 percent in January 2024